相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease
Hugo Geerts et al.
FRONTIERS IN PHARMACOLOGY (2013)
A Quantitative System Pharmacology Computer Model for Cognitive Deficits in Schizophrenia
H. Geerts et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Quantitative Systems Pharmacology Model of NO Metabolome and Methemoglobin Following Long-Term Infusion of Sodium Nitrite in Humans
K. Vega-Villa et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
If we designed airplanes like we design drugsaEuro¦
Walter S. Woltosz
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development
Ashley Strougo et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
Balaji M. Agoram et al.
DRUG DISCOVERY TODAY (2011)
The productivity crisis in pharmaceutical R&D
Fabio Pammolli et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks
Thomas Eissing et al.
FRONTIERS IN PHYSIOLOGY (2011)
The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse
L. Shoda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
The FDA critical path initiative and its influence on new drug development
Janet Woodcock et al.
ANNUAL REVIEW OF MEDICINE (2008)
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N. Edginton et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
The Cost of Biopharmaceutical R&D: Is Biotech Different?
Joseph A. DiMasi et al.
MANAGERIAL AND DECISION ECONOMICS (2007)
A strategy for preclinical formulation development using GastroPlus (TM) as pharmacokinetic simulation tool and a statistical screening design applied to a dog study
M Kuentz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
分享论文
